SCHEMBL24865744

SCHEMBL24865744

Cc1c(Nc2ccc3c(c2)n(C)c(=O)n3C)ccc(N2CCC(C)CC2)c1C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BCL6 P41182 3/20 0.40
HSD17B10 Q99714 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 3/20 0.40
TP53 P04637 1/20 0.40
GAA P10253 4/20 0.39
KDM4E B2RXH2 3/20 0.39
TRIM24 O15164 2/20 0.38
MAPT P10636 3/20 0.37
LMNA P02545 2/20 0.37
HTT P42858 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAPK1 P28482 1/20 0.36
POLB P06746 1/20 0.36
NR4A1 P22736 1/20 0.36
BRPF1 P55201 2/20 0.36
BRD4 O60885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31123320 0.91 BCL6 (0.39) BCL6HSD17B10SMN1; SMN2ALDH1A1TP53
SCHEMBL24865635 0.91 BCL6 (0.39) BCL6HSD17B10SMN1; SMN2ALDH1A1TP53
SCHEMBL30336449 0.90 BCL6 (0.38) BCL6HSD17B10SMN1; SMN2ALDH1A1TP53
SCHEMBL24865227 0.90 BCL6 (0.38) BCL6HSD17B10SMN1; SMN2ALDH1A1TP53
SCHEMBL24865509 0.85 SMN1; SMN2 (0.42) BCL6HSD17B10SMN1; SMN2ALDH1A1TP53
SCHEMBL30336503 0.83 ALDH1A1 (0.48) BCL6HSD17B10SMN1; SMN2ALDH1A1TP53
SCHEMBL24865649 0.83 ALDH1A1 (0.48) BCL6HSD17B10SMN1; SMN2ALDH1A1TP53
SCHEMBL24865039 0.82 PIK3CA (0.46) BCL6HSD17B10SMN1; SMN2ALDH1A1TP53
SCHEMBL24865630 0.82 GAA (0.46) HSD17B10SMN1; SMN2ALDH1A1TP53GAA
SCHEMBL30336382 0.82 GAA (0.46) HSD17B10SMN1; SMN2ALDH1A1TP53GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 US disclosed
CN-117999259-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-07 CN disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 BCL6 390/4885HSD17B10 1245/4885SMN1; SMN2 1657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.